Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 juin 2016 12h00 HE | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Results of Phase 1 Trial of Marizomib and Bevacizumab in Malignant Glioma

TORONTO and SAN DIEGO, June 04, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept,...
03 mai 2016 09h35 HE | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Expansion of Collaboration with Celgene in the Development of Marizomib for the Treatment of Gliomas

TORONTO and SAN DIEGO, May 03, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept,...
19 avr. 2016 09h05 HE | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Interim Results of Phase 1 Trial of Marizomib and Bevacizumab in Malignant Glioma

TORONTO and SAN DIEGO, April 19, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2...
18 avr. 2016 09h05 HE | Source: Triphase Accelerator

Triphase Accelerator Corporation Announces Positive Preclinical Results for CBZed-Nano™ in Docetaxel-Resistant Prostate Cancer Models

TORONTO and SAN DIEGO, April 18, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2...

Page précédente